Safety and Preliminary Efficacy of Dexpramipexole in Patients With Chronic Sinusitis With Nasal Polyps and Eosinophilia (CSNP-E)
Phase of Trial: Phase II
Latest Information Update: 07 Mar 2017
At a glance
- Drugs Dexpramipexole (Primary)
- Indications Eosinophilia; Nasal polyps; Sinusitis
- Focus Therapeutic Use
- Sponsors Knopp Biosciences
- 07 Mar 2017 According to a Knopp Biosciences media release, results from this study were presented at 2017 American Academy of Allergy and Immunology (AAAAI).
- 07 Mar 2017 Results published in the Knopp Biosciences media release.
- 06 Mar 2017 Results (n=11) presented at the 2017 Annual Meeting of the American Academy of Allergy, Asthma and Immunology